The DOI matches its Crossref record.
The Cost Effectiveness of Apligraf?? Treatment of Diabetic Foot Ulcers
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As noted, its use has been found to decrease the risk of development of osteomyelitis (Veves et al 2001) and the risk of amputation in diabetic patients (Veves et al 2001; Redekop et al 2003), and improve the quality of life of patients with chronic VLU, mainly by reducing wound pain (Mathias et al 2000).”
From A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers (2007) · cites this paper as Redekop et al 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 11
- Moss, 1992, Arch Intern Med, 152, 610, 10.1001/archinte.1992.00400150120022 · DOI
- Apelqvist, 1994, J Intern Med, 235, 463, 10.1111/j.1365-2796.1994.tb01104.x · DOI
- Apelqvist, 1995, Foot Ankle Int, 16, 388, 10.1177/107110079501600702 · DOI
- Ollendorf, 1998, Diabetes Care, 21, 1240, 10.2337/diacare.21.8.1240 · DOI
- Veves, 2001, Diabetes Care, 24, 290, 10.2337/diacare.24.2.290 · DOI · Paper page
- Ghatnekar, 2001, Pharmacoeconomics, 19, 767, 10.2165/00019053-200119070-00005 · DOI
- Wagner Jr, 1981, Foot Ankle, 2, 64, 10.1177/107110078100200202 · DOI
- van Houtum, 1995, Diabet Med, 12, 777, 10.1111/j.1464-5491.1995.tb02079.x · DOI
- van Houtum, 1996, J Diabetes Complications, 10, 325, 10.1016/1056-8727(95)00088-7 · DOI
- Brem, 2000, Arch Surg, 135, 627, 10.1001/archsurg.135.6.627 · DOI
- Allenet, 2000, Diabete Metab, 26, 125
Cited by
Zaulyanov, L., & Kirsner, R. S. (2007) · Clinical Interventions in Aging · doi:10.2147/ciia.2007.2.1.93 · Cited by 266
Metadata
- Authors
- Redekop, W. K., McDonnell, J., Verboom, P., Lovas, K., & Kalo, Z.
- Venue
- PharmacoEconomics
- Published
- 2003
- Volume
- 21
- Issue
- 16
- Pages
- 1171-1183
- ISSN
- 1170-7690
- Cited by
- 56
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
